MAPK3 and prostate cancer: These data demonstrate that after GPCR activation, Gβγ translocation to the GA which subsequently activates PI3Kγ and ARF1 may provide a common pathway by which multiple GPCRs activate the MAPKs ERK1/2 in prostate cancer cells.